The heavy commercial vehicle maker reported over two-fold rise in net profit at Rs 287 crore for the second quarter ended September 30, 2015. The Chennai-based company had posted a net profit of Rs 121 crore during the same period of previous fiscal.
Posts tagged MC
Commercial vehicles industry to grow at 20%: Ashok Leyland (06-11-2015)
See strong H2, betting on acquisitions: Talwalkars (06-11-2015)
Anant Gawande, CFO, Talwalkars says the recently signed acquisitions are with small and medium enterprises companies that have both high EBITDA and return on equity.
Virtusa deal a win-win for staff, customers: Polaris’s Jain (06-11-2015)
Virtusa Corporation has signed a definitive agreement to acquire 53 percent in Polaris Consulting Services at Rs 220.73 per share
Buy India Cements; target of Rs 112: Angel Broking (06-11-2015)
Angel Broking is bullish on India Cements and has recommended buy rating on the stock with a target of Rs 112 in its November 3, 2015 research report.
Buy Lakshmi Machine Works; target of Rs 4500: Religare (06-11-2015)
Religare is bullish on Lakshmi Machine Works and has recommended buy rating on the stock with a target of Rs 4500 in its November 3, 2015 research report.
Accumulate GAIL; target of Rs 338: KR Choksey (06-11-2015)
KR Choksey is bullish on GAIL and has recommended ‘Accumulate’ rating on the stock with a target price of Rs 338 in its research report dated November 3, 2015
Buy Indoco Remedies; target of Rs 400: ICICI Direct (06-11-2015)
ICICI Direct is bullish on Indoco Remedies and has recommended buy rating on the stock with a target of Rs 400 in its November 04, 2015 research report.
Buy Blue Star; target of Rs 478; Dolat Capital (06-11-2015)
Dolat Capital is bullish on Blue Star and has recommended ‘Accumulate’ rating on the stock with a target price of Rs 478 in its research report dated November 4, 2015
SREI Equipment Fin to raise up to Rs 500 cr via bonds (06-11-2015)
“SREI Equipment Finance Pvt Ltd has informed BSE that the Board of Directors of the Company at its meeting held on November 5, 2015, has approved public issue of…redeemable, non-convertible debentures of face value of Rs 1,000 each, aggregating upto Rs 500 crores,” it said in a filing on BSE.
Dr Reddy’s tanks 11% post warning letter from USFDA (06-11-2015)
The warning letter is relating to its API manufacturing facilities at Srikakulam, Andhra Pradesh and Miryalaguda, Telangana, as well as Oncology Formulation manufacturing facility at Duvvada, Visakhapatnam, Andhra Pradesh.